[chuie]

I have a hard time believing that large pharma research labs are limiting themselves to single loci for a given disease phenotype. But if they are, it makes sense why YC would see value in this.

[bbgm]

They haven't for a while. Some of the claims, at least in this story, are way over the top.

[mswen]

They aren't

[chuie]

I'm going to presume that I don't really understand the company then, because the founders and advisers should certainly know more than I do about drug discovery.